Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep 17;583(18):3004-8.
doi: 10.1016/j.febslet.2009.07.060. Epub 2009 Aug 6.

Molecular immune signatures of HIV-1 vaccines in human PBMCs

Alessandro Monaco  1 , Francesco M Marincola, Marianna Sabatino, Zoltan Pos, Maria Lina Tornesello, David F Stroncek, Ena Wang, George K Lewis, Franco M Buonaguro, Luigi Buonaguro
Affiliations

Molecular immune signatures of HIV-1 vaccines in human PBMCs

Alessandro Monaco et al. FEBS Lett. .

Abstract

The global transcriptional profile of peripheral blood mononuclear cells (PBMCs) stimulated with HIV candidate vaccine (virus-like particles, VLPs) has been evaluated in HIV-infected patients with low/high viral load compared to healthy volunteers. Baseline activation of chemokine production was observed in PBMC from HIV-infected patients and innate immune stimulation with HIV-VLPs was not blunted. The immune profile among HIV-infected patients was found to be qualitatively similar but quantitatively extremely variable. This diversity was independent of viral load and it might be dependent on individual immunogenetic traits or concurrent immunological status. This ex vivo screening strategy represents an efficient tool for guiding modifications/optimizations of vaccination strategies and understanding failures in individuals enrolled in clinical trials.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Self-organizing heat map based on genes with immune annotation according to Gene Ontology, most differentially expressed in unstimulated PBMCs from normal volunteers compared to PBMCs stimulated with VLPs or LPS in the same cohort.
Fig. 2
Fig. 2
(A) Self-organizing heat map representing 1097 genes differentially expressed in PBMC. The red and yellow arrows points to subjects #12 and #5, respectively, who were found anergic to VLP-stimulation among the high and low-viremia patients. (B) Immune genes selected, among those identified according to the criteria in panel A, according the list in Fig. 1.
Fig. 3
Fig. 3
Unsupervised hierarchical clustering of PBMC samples stimulated with LPS (A) or VLPs (B). High stringent filter was applied resulting in the inclusion of 4,529 cDNA clones. Venn Diagram comparing the overlap of genes differentially expressed in PBMCs upon stimulation with LPS (B) or VLPs (D).
Fig. 4
Fig. 4
(A) Self-organizing heat map based on 156 genes with immune annotations according to gene ontology modulated at high degree of significance by stimulation with either VLPs or LPS. The orange dashed line emphasizes the ISGs cluster (a); the blue dashed line emphasizes the lymphokine pattern (b). (B) The yellow and red arrows point to patient 05 and 12, respectively.
Fig. 5
Fig. 5
(A–E) Relative Cy5/Cy3 values of IL-6, IL-8, CCL3, CCL22 and IRF-7 in different patient cohorts and type of stimulation. Data represent cumulative Cy5/Cy3 values for each experimental category. Red, yellow and green boxes indicate high–low-viral load and healthy normal controls, respectively. (*, **, *** = P-value <0.05, <01 and <0.001, respectively) [15].
See this image and copyright information in PMC

References

    1. Buonaguro L, Buonaguro FM, Tornesello ML, Mantas D, Beth-Giraldo E, Wagner R, Michelsonr S, Prevost M-C, Wolf H, Giraldo G. High efficient production of Pr55gag Virus-like Particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A. Antiviral Res. 2001;49:35–47. - PubMed
    1. Buonaguro L, Racioppi L, Tornesello ML, Arra C, Visciano ML, Biryahwaho B, Sempala SDK, Giraldo G, Buonaguro FM. Induction of neutralizing antibodies and CTLs in Balb/c mice immunized with Virus-like Particles presenting a gp120 molecule from a HIV-1 isolate of clade A (HIV-VLPAs) Antiviral Res. 2002;54:189–201. - PubMed
    1. Buonaguro L, Visciano ML, Tornesello ML, Tagliamonte M, Biryahwaho B, Buonaguro FM. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation. J. Virol. 2005;79:7059–7067. - PMC - PubMed
    1. Buonaguro L, Devito C, Tornesello ML, Schroder U, Wahren B, Hinkula J, Buonaguro FM. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity. Vaccine. 2007;25:5968–5977. - PubMed
    1. Buonaguro L, Tornesello ML, Tagliamonte M, Gallo RC, Wang LX, Kamin-Lewis R, Abdelwahab S, Lewis GK, Buonaguro FM. Baculovirus-derivedhumanimmunodeficiencyvirustype1virus-likeparticlesactivatedendriticcellsandinduceexvivoT-cellresponses. JVirol. 2006;80:9134–9143. - PMC - PubMed

Publication types